Publications from the Centre for Immuno-Oncology
Adsorption of antigen to polymeric nanoparticles enhances cytotoxic T-cell responses and anti-tumor immunity by targeting conventional type 1 dendritic cells.
Huete-Carrasco J. et al, (2025), Immunology and cell biology
Intratumoral delivery of the chitin-derived C100 adjuvant promotes robust STING, IFNAR, and CD8+ T cell-dependent anti-tumor immunity
Turley JL. et al, (2024), Cell Reports Medicine, 5, 101560 - 101560
Rational design of polymer‐based particulate vaccine adjuvants
Huete‐Carrasco J. et al, (2024), European Journal of Immunology, 54
Immunostimulatory nanoparticles go viral
Huete-Carrasco J. and Lavelle EC., (2023), Nature Materials, 22, 273 - 275
[Bladder cancer immunological background and biomarkers.].
Valés-Gómez M. et al, (2020), Arch Esp Urol, 73, 895 - 905
PD-1 suppresses the maintenance of cell couples between cytotoxic T cells and target tumor cells within the tumor.
Ambler R. et al, (2020), Science signaling, 13